Stock screenerAll disclosures →
EDGAR →
AMLX
Conviction 84HealthcareScan · Mon, Aug 10, 2026AMLX$22.65-0.74%
ResistanceSupportVol 14Insider buyInsider sellVol MA14 2.36M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price22.65
Change-0.74%
Gap-0.31%
Rel volume1.19×
Avg volume2.12M
Avg $ vol42.97M
SMA 2019.69
SMA 5017.43
SMA 20015.05
Price vs 50+29.97%
Price vs 200+50.51%
MA stackbullish
50/200 cross—
Supertrendup · 19.05
RSI (14)67
MACD hist0.33
MACD crossbull · 9d
Stoch %K / %D74 / 83
ADX (14)44
+DI / −DI32 / 8
RSI divergenceBearish
MACD divergenceBearish
ATR %+6.07%
ADR %7.04%
52w high24.19
52w low7.64
From 52w high-6.37%
Above 52w low+196.47%
New 52w highNo
SqueezeOff
Bollinger width41.44%
%B0.86
Donchian pos75.87%
Donchian high24.60
Donchian low16.52
AVWAP (52w high)22.96
vs AVWAP high-1.34%
AVWAP (52w low)14.56
vs AVWAP low+55.51%
OBV trendUp
Chaikin MF (20)0.29
Today vs 20d1.19×
Avg vol (14d)2.36M
Avg vol (20d)2.12M
Avg $ vol (20d)42.97M
Market cap2.52B
RS 3m (vs SPY)+44.43%
RS 6m (vs SPY)+61.56%
RS line new highNo
Trend template8/8
Technical rank93.3
1 week+12.30%
1 month+27.46%
3 months+53.77%
6 months+62.02%
1 year+188.90%
YTD+98.34%
P/E-17.44
P/B10.55
P/S—
P/FCF-20.44
EPS-1.53
Div yield—
ROE-60.52%
ROA-54.71%
Debt/Eq—
Current12.12
EV/EBITDA—
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth52.03%
Price target28.63
Target upside26.40%
Analyst ratingBuy
Institutional108.97%
Ent. value2.47B
Revenue0
Net income-43.42M
Gross profit—
Free cash flow-123.48M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out111.19M
Employees136
ListedFri, Jan 7, 2022
Free float87.41M
Float %79.6%
Short interest12.27M
Days to cover9.2d
Short volume62.8%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.39 vs −$0.36
Last surprise-8.3% miss
Setup gradeA
Conviction84 / 100
Pattern quality—
Tech rank93.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.05
Support16.74
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJun 111 scan
- Breaking out nowJun 121 scan
- Setting upJul 8 – Jul 143 scans
Congress activity
Disclosed STOCK Act trades in AMLX
No recent disclosed trades by Congress in AMLX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AMLX · 6 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mazzariello Gina Chief Legal Officer · Common Stock · 2026-07-10 | Sell | 15K | $264K | 2026-07-10 | 2026-07-13 |
Mazzariello Gina Chief Legal Officer · Common Stock · 2026-07-09 | Sell | 15K | $275K | 2026-07-09 | 2026-07-13 |
Quimi Daphne Director · Stock Option (right to buy) · 2026-06-04 | Grant | 24.37K | $0 | 2026-06-04 | 2026-06-08 |
MILNE GEORGE M JR Director · Stock Option (right to buy) · 2026-06-04 | Grant | 24.37K | $0 | 2026-06-04 | 2026-06-08 |
Firestone Karen Director · Stock Option (right to buy) · 2026-06-04 | Grant | 24.37K | $0 | 2026-06-04 | 2026-06-08 |
Zeiher Bernhardt G Director · Stock Option (right to buy) · 2026-06-04 | Grant | 24.37K | $0 | 2026-06-04 | 2026-06-08 |
FONTEYNE PAUL R. Director · Stock Option (right to buy) · 2026-06-04 | Grant | 24.37K | $0 | 2026-06-04 | 2026-06-08 |
Firestone Karen Director · Common Stock · 2026-05-21 | Buy | 3.8K | $51K | 2026-05-21 | 2026-05-26 |
SEC filings
EDGAR filings in AMLX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.